comparemela.com

Latest Breaking News On - Michaeld wortley - Page 1 : comparemela.com

Reata Pharmaceuticals, Inc (NASDAQ:RETA) Receives $114 40 Average PT from Brokerages

Reata Pharmaceuticals, Inc. (NASDAQ:RETA – Get Free Report) has received a consensus recommendation of “Hold” from the thirteen analysts that are presently covering the company, Marketbeat Ratings reports. Nine investment analysts have rated the stock with a hold recommendation and four have assigned a buy recommendation to the company. The average twelve-month price target among […]

Citigroup Downgrades Reata Pharmaceuticals (NASDAQ:RETA) to Neutral

Citigroup cut shares of Reata Pharmaceuticals (NASDAQ:RETA – Free Report) from a buy rating to a neutral rating in a research report released on Tuesday morning, Marketbeat reports. Citigroup currently has $172.50 target price on the stock, up from their prior target price of $127.00. Other equities analysts have also recently issued reports about the […]

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.